Skip to main content

Animations

MJFF Publications

1861 - 1870 of 8819 Results
Title
Year
  • Year
  • 2022
  • 2021
  • 2022
  • 2023
  • 2023
  • 2023
  • 2023
  • 2022
  • 2023
  • 2021
  • Summary Details
    OPEN
    Title: Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegeneration
    Journal Name: PLOS Genetics
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pgen.1010138
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo‐Controlled Trial of Rasagiline
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28838
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Sleep, Pain, and Neurodegeneration: A Mendelian Randomization Study
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.765321
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Organ aging signatures in the plasma proteome track health and disease
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41586-023-06802-1
    Citation Count: 326
  • Summary Details
    OPEN
    Title: Senescent Schwann cells induced by aging and chronic denervation impair axonal regeneration following peripheral nerve injury
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.202317907
    Citation Count: 31
  • Summary Details
    OPEN
    Title: In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain–striatum–cortex assembloids
    Journal Name: Nature Methods
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41592-023-02080-x
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00604-y
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Alzheimer’s Disease Variant Portal: A Catalog of Genetic Findings for Alzheimer’s Disease
    Journal Name: Journal of Alzheimer's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jad-215055
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Population fraction of Parkinson’s disease attributable to preventable risk factors
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00603-z
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure
    Journal Name: Advanced Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/advs.202101462
    Citation Count: 140
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.